FDAnews Drug Daily Bulletin

FDA Tacks On Another Chinese Drugmaker to Import Ban List

May 31, 2016

The FDA has banned imports from another Chinese drugmaker, ordering that its products be detained without physical examination for failing to meet GMP standards.

The agency flagged nine drugs from Yunnan Hande Bio-Tech’s API production facility in Kunming, Yunnan.

It is the sixth Chinese manufacturer to be flagged this month.

View today's stories